Tfe3 and Tfeb Transcriptionally Regulate Peroxisome Proliferator-Activated Receptor γ2 Expression in Adipocytes and Mediate Adiponectin and Glucose Levels in Mice

REFERENCES

• Steingrimsson E, Tessarollo L, Pathak B, Hou L, Arnheiter H, Copeland NG, Jenkins NA. 2002. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. Proc Natl Acad Sci U S A 99:4477–4482. https://doi.org/10.1073/pnas.072071099.
   PubMed Web of Science ®Google Scholar
• Beckmann H, Kadesch T. 1991. The leucine zipper of TFE3 dictates helix-loop-helix dimerization specificity. Genes Dev 5:1057–1066. https://doi.org/10.1101/gad.5.6.1057.
   PubMedGoogle Scholar
• Fisher DE, Carr CS, Parent LA, Sharp PA. 1991. TFEB has DNA-binding and oligomerization properties of a unique helix-loop-helix/leucine-zipper family. Genes Dev 5:2342–2352. https://doi.org/10.1101/gad.5.12a.2342.
   PubMed Web of Science ®Google Scholar
• Hemesath TJ, Steingrimsson E, McGill G, Hansen MJ, Vaught J, Hodgkinson CA, Arnheiter H, Copeland NG, Jenkins NA, Fisher DE. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:2770–2780. https://doi.org/10.1101/gad.8.22.2770.
   PubMed Web of Science ®Google Scholar
• Katayama R, Yamane A, Fukui T. 2010. Changes in the expression of myosins during postnatal development of masseter muscle in the microphthalmic mouse. Open Dent J 4:1–7. https://doi.org/10.2174/1874210601004010001.
   PubMedGoogle Scholar
• Naka A, Iida KT, Nakagawa Y, Iwasaki H, Takeuchi Y, Satoh A, Matsuzaka T, Ishii KA, Kobayashi K, Yatoh S, Shimada M, Yahagi N, Suzuki H, Sone H, Yamada N, Shimano H. 2013. TFE3 inhibits myoblast differentiation in C2C12 cells via down-regulating gene expression of myogenin. Biochem Biophys Res Commun 430:664–669. https://doi.org/10.1016/j.bbrc.2012.11.094.
   PubMedGoogle Scholar
• Ooishi R, Shirai M, Funaba M, Murakami M. 2012. Microphthalmia-associated transcription factor is required for mature myotube formation. Biochim Biophys Acta 1820:76–83. https://doi.org/10.1016/j.bbagen.2011.11.005.
   PubMedGoogle Scholar
• Zanocco-Marani T, Vignudelli T, Parenti S, Gemelli C, Condorelli F, Martello A, Selmi T, Grande A, Ferrari S. 2009. TFE3 transcription factor regulates the expression of MAFB during macrophage differentiation. Exp Cell Res 315:1798–1808. https://doi.org/10.1016/j.yexcr.2009.03.018.
   PubMedGoogle Scholar
• Fujimoto Y, Nakagawa Y, Satoh A, Okuda K, Shingyouchi A, Naka A, Matsuzaka T, Iwasaki H, Kobayashi K, Yahagi N, Shimada M, Yatoh S, Suzuki H, Yogosawa S, Izumi T, Sone H, Urayama O, Yamada N, Shimano H. 2013. TFE3 controls lipid metabolism in adipose tissue of male mice by suppressing lipolysis and thermogenesis. Endocrinology 154:3577–3588. https://doi.org/10.1210/en.2013-1203.
   PubMedGoogle Scholar
• Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F, Visvikis O, Huynh T, Carissimo A, Palmer D, Klisch TJ, Wollenberg AC, Di Bernardo D, Chan L, Irazoqui JE, Ballabio A. 2013. TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat Cell Biol 15:647–658. https://doi.org/10.1038/ncb2718.
   PubMed Web of Science ®Google Scholar
• Betschinger J, Nichols J, Dietmann S, Corrin PD, Paddison PJ, Smith A. 2013. Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell 153:335–347. https://doi.org/10.1016/j.cell.2013.03.012.
   PubMed Web of Science ®Google Scholar
• Steingrímsson E, Tessarollo L, Reid SW, Jenkins NA, Copeland NG. 1998. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 125:4607–4616.
   PubMed Web of Science ®Google Scholar
• Davis IJ, Kim JJ, Ozsolak F, Widlund HR, Rozenblatt-Rosen O, Granter SR, Du J, Fletcher JA, Denny CT, Lessnick SL, Linehan WM, Kung AL, Fisher DE. 2006. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers. Cancer Cell 9:473–484. https://doi.org/10.1016/j.ccr.2006.04.021.
   PubMed Web of Science ®Google Scholar
• Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ, Bottaro DP, Srinivasan R, Linehan WM. 2014. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol 11:465–475. https://doi.org/10.1038/nrurol.2014.162.
   PubMed Web of Science ®Google Scholar
• Nakagawa Y, Shimano H, Yoshikawa T, Ide T, Tamura M, Furusawa M, Yamamoto T, Inoue N, Matsuzaka T, Takahashi A, Hasty AH, Suzuki H, Sone H, Toyoshima H, Yahagi N, Yamada N. 2006. TFE3 transcriptionally activates hepatic IRS-2, participates in insulin signaling and ameliorates diabetes. Nat Med 12:107–113. https://doi.org/10.1038/nm1334.
   PubMedGoogle Scholar
• Iwasaki H, Naka A, Iida KT, Nakagawa Y, Matsuzaka T, Ishii KA, Kobayashi K, Takahashi A, Yatoh S, Yahagi N, Sone H, Suzuki H, Yamada N, Shimano H. 2012. TFE3 regulates muscle metabolic gene expression, increases glycogen stores, and enhances insulin sensitivity in mice. Am J Physiol Endocrinol Metab 302:E896–E902. https://doi.org/10.1152/ajpendo.00204.2011.
   PubMedGoogle Scholar
• Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M, Gennarino VA, Di Malta C, Donaudy F, Embrione V, Polishchuk RS, Banfi S, Parenti G, Cattaneo E, Ballabio A. 2009. A gene network regulating lysosomal biogenesis and function. Science 325:473–477.
   PubMed Web of Science ®Google Scholar
• Martina JA, Diab HI, Lishu L, Jeong AL, Patange S, Raben N, Puertollano R. 2014. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 7:ra9. https://doi.org/10.1126/scisignal.2004754.
   PubMed Web of Science ®Google Scholar
• Weilbaecher KN, Motyckova G, Huber WE, Takemoto CM, Hemesath TJ, Xu Y, Hershey CL, Dowland NR, Wells AG, Fisher DE. 2001. Linkage of M-CSF signaling to Mitf, TFE3, and the osteoclast defect in Mitf(mi/mi) mice. Mol Cell 8:749–758. https://doi.org/10.1016/S1097-2765(01)00360-4.
   PubMedGoogle Scholar
• Levy C, Khaled M, Fisher DE. 2006. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12:406–414. https://doi.org/10.1016/j.molmed.2006.07.008.
   PubMed Web of Science ®Google Scholar
• Hodgkinson CA, Moore KJ, Nakayama A, Steingrimsson E, Copeland NG, Jenkins NA, Arnheiter H. 1993. Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74:395–404. https://doi.org/10.1016/0092-8674(93)90429-T.
   PubMed Web of Science ®Google Scholar
• Farmer SR. 2006. Transcriptional control of adipocyte formation. Cell Metab 4:263–273. https://doi.org/10.1016/j.cmet.2006.07.001.
   PubMed Web of Science ®Google Scholar
• Lee JE, Ge K. 2014. Transcriptional and epigenetic regulation of PPARgamma expression during adipogenesis. Cell Biosci 4:29. https://doi.org/10.1186/2045-3701-4-29.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. 2000. Molecular regulation of adipogenesis. Annu Rev Cell Dev Biol 16:145–171. https://doi.org/10.1146/annurev.cellbio.16.1.145.
   PubMed Web of Science ®Google Scholar
• Kawai M, Rosen CJ. 2010. PPARgamma: a circadian transcription factor in adipogenesis and osteogenesis. Nat Rev Endocrinol 6:629–636. https://doi.org/10.1038/nrendo.2010.155.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK. 1995. Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms. Proc Natl Acad Sci U S A 92:7921–7925. https://doi.org/10.1073/pnas.92.17.7921.
   PubMed Web of Science ®Google Scholar
• Vidal-Puig A, Jimenez-Linan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE. 1996. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents. J Clin Invest 97:2553–2561. https://doi.org/10.1172/JCI118703.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM. 1994. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224–1234. https://doi.org/10.1101/gad.8.10.1224.
   PubMed Web of Science ®Google Scholar
• Semple RK, Chatterjee VK, O'Rahilly S. 2006. PPAR gamma and human metabolic disease. J Clin Invest 116:581–589. https://doi.org/10.1172/JCI28003.
   PubMed Web of Science ®Google Scholar
• Siersbaek R, Nielsen R, Mandrup S. 2010. PPARgamma in adipocyte differentiation and metabolism—novel insights from genome-wide studies. FEBS Lett 584:3242–3249. https://doi.org/10.1016/j.febslet.2010.06.010.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, Noda M, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8:1288–1295. https://doi.org/10.1038/nm788.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Spiegelman BM. 2006. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 444:847–853. https://doi.org/10.1038/nature05483.
   PubMed Web of Science ®Google Scholar
• Boezaart AP, Tighe P. 2010. New trends in regional anesthesia for shoulder surgery: avoiding devastating complications. Int J Shoulder Surg 4:1–7. https://doi.org/10.4103/0973-6042.68410.
   PubMedGoogle Scholar
• Gil-Dones F, Martin-Rojas T, Lopez-Almodovar LF, de la Cuesta F, Darde VM, Alvarez-Llamas G, Juarez-Tosina R, Barroso G, Vivanco F, Padial LR, Barderas MG. 2010. Valvular aortic stenosis: a proteomic insight. Clin Med Insights Cardiol 4:1–7.
   PubMedGoogle Scholar
• Green H, Meuth M. 1974. An established pre-adipose cell line and its differentiation in culture. Cell 3:127–133. https://doi.org/10.1016/0092-8674(74)90116-0.
   PubMed Web of Science ®Google Scholar
• Tontonoz P, Hu E, Spiegelman B. 1994. Stimulation of adipogenesis in fibroblasts by PPARg2, a lipid activated transcription factor. Cell 79:1147–1156. https://doi.org/10.1016/0092-8674(94)90006-X.
   PubMed Web of Science ®Google Scholar
• Cao Z, Umek RM, McKnight SL. 1991. Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538–1552. https://doi.org/10.1101/gad.5.9.1538.
   PubMed Web of Science ®Google Scholar
• Hemesath TJ, Price ER, Takemoto C, Badalian T, Fisher DE. 1998. MAP kinase links the transcription factor Microphthalmia to c-Kit signalling in melanocytes. Nature 391:298–301. https://doi.org/10.1038/34681.
   PubMed Web of Science ®Google Scholar
• Rehli M, Den Elzen N, Cassady AI, Ostrowski MC, Hume DA. 1999. Cloning and characterization of the murine genes for bHLH-ZIP transcription factors TFEC and TFEB reveal a common gene organization for all MiT subfamily members. Genomics 56:111–120. https://doi.org/10.1006/geno.1998.5588.
   PubMed Web of Science ®Google Scholar
• Roman C, Matera AG, Cooper C, Artandi S, Blain S, Ward DC, Calame K. 1992. mTFE3, an X-linked transcriptional activator containing basic helix-loop-helix and zipper domains, utilizes the zipper to stabilize both DNA binding and multimerization. Mol Cell Biol 12:817–827. https://doi.org/10.1128/MCB.12.2.817.
   PubMedGoogle Scholar
• Prusty D, Park BH, Davis KE, Farmer SR. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor gamma (PPARgamma) and C/EBPalpha gene expression during the differentiation of 3T3-L1 preadipocytes. J Biol Chem 277:46226–46232. https://doi.org/10.1074/jbc.M207776200.
   PubMed Web of Science ®Google Scholar
• Lefterova MI, Zhang Y, Steger DJ, Schupp M, Schug J, Cristancho A, Feng D, Zhuo D, Stoeckert CJ, Jr, Liu XS, Lazar MA. 2008. PPARgamma and C/EBP factors orchestrate adipocyte biology via adjacent binding on a genome-wide scale. Genes Dev 22:2941–2952. https://doi.org/10.1101/gad.1709008.
   PubMed Web of Science ®Google Scholar
• Campeau E, Ruhl VE, Rodier F, Smith CL, Rahmberg BL, Fuss JO, Campisi J, Yaswen P, Cooper PK, Kaufman PD. 2009. A versatile viral system for expression and depletion of proteins in mammalian cells. PLoS One 4:e6529. https://doi.org/10.1371/journal.pone.0006529.
   PubMed Web of Science ®Google Scholar
• Wu Z, Xie Y, Bucher NL, Farmer SR. 1995. Conditional ectopic expression of C/EBP beta in NIH-3T3 cells induces PPAR gamma and stimulates adipogenesis. Genes Dev 9:2350–2363. https://doi.org/10.1101/gad.9.19.2350.
   PubMed Web of Science ®Google Scholar
• Rosen ED, Hsu CH, Wang X, Sakai S, Freeman MW, Gonzalez FJ, Spiegelman BM. 2002. C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes Dev 16:22–26. https://doi.org/10.1101/gad.948702.
   PubMed Web of Science ®Google Scholar
• Nielsen R, Pedersen TA, Hagenbeek D, Moulos P, Siersbaek R, Megens E, Denissov S, Borgesen M, Francoijs KJ, Mandrup S, Stunnenberg HG. 2008. Genome-wide profiling of PPARgamma:RXR and RNA polymerase II occupancy reveals temporal activation of distinct metabolic pathways and changes in RXR dimer composition during adipogenesis. Genes Dev 22:2953–2967. https://doi.org/10.1101/gad.501108.
   PubMed Web of Science ®Google Scholar
• Salma N, Xiao H, Mueller E, Imbalzano AN. 2004. Temporal recruitment of transcription factors and SWI/SNF chromatin-remodeling enzymes during adipogenic induction of the peroxisome proliferator-activated receptor gamma nuclear hormone receptor. Mol Cell Biol 24:4651–4663. https://doi.org/10.1128/MCB.24.11.4651-4663.2004.
   PubMed Web of Science ®Google Scholar
• Walczak R, Tontonoz P. 2002. PPARadigms and PPARadoxes: expanding roles for PPARgamma in the control of lipid metabolism. J Lipid Res 43:177–186.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Oresic M, Vidal-Puig A. 2012. Peroxisome proliferator-activated receptor gamma-dependent regulation of lipolytic nodes and metabolic flexibility. Mol Cell Biol 32:1555–1565. https://doi.org/10.1128/MCB.06154-11.
   PubMedGoogle Scholar
• Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kuriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, Matsuzawa Y. 2000. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595–1599. https://doi.org/10.1161/01.ATV.20.6.1595.
   PubMed Web of Science ®Google Scholar
• Liu Q, Yuan B, Lo KA, Patterson HC, Sun Y, Lodish HF. 2012. Adiponectin regulates expression of hepatic genes critical for glucose and lipid metabolism. Proc Natl Acad Sci U S A 109:14568–14573. https://doi.org/10.1073/pnas.1211611109.
   PubMed Web of Science ®Google Scholar
• Ghoshal K, Bhattacharyya M. 2015. Adiponectin: probe of the molecular paradigm associating diabetes and obesity. World J Diabetes 6:151–166. https://doi.org/10.4239/wjd.v6.i1.151.
   PubMed Web of Science ®Google Scholar
• Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L. 2001. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875–1881. https://doi.org/10.1172/JCI14120.
   PubMed Web of Science ®Google Scholar
• Lihn AS, Pedersen SB, Richelsen B. 2005. Adiponectin: action, regulation and association to insulin sensitivity. Obes Rev 6:13–21. https://doi.org/10.1111/j.1467-789X.2005.00159.x.
   PubMed Web of Science ®Google Scholar
• Tokunaga C, Yoshino K, Yonezawa K. 2004. mTOR integrates amino acid- and energy-sensing pathways. Biochem Biophys Res Commun 313:443–446. https://doi.org/10.1016/j.bbrc.2003.07.019.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. 2013. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 126:1713–1719. https://doi.org/10.1242/jcs.125773.
   PubMed Web of Science ®Google Scholar
• Laplante M, Sabatini DM. 2012. mTOR signaling in growth control and disease. Cell 149:274–293. https://doi.org/10.1016/j.cell.2012.03.017.
   PubMed Web of Science ®Google Scholar
• Martina JA, Chen Y, Gucek M, Puertollano R. 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:903–914. https://doi.org/10.4161/auto.19653.
   PubMed Web of Science ®Google Scholar
• Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J, Angarola B, Walther TC, Ferguson SM. 2012. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5:ra42. https://doi.org/10.1126/scisignal.2002790.
   PubMed Web of Science ®Google Scholar
• Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S, Erdin S, Huynh T, Ferron M, Karsenty G, Vellard MC, Facchinetti V, Sabatini DM, Ballabio A. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31:1095–1108. https://doi.org/10.1038/emboj.2012.32.
   PubMed Web of Science ®Google Scholar
• Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F, Erdin S, Erdin SU, Huynh T, Medina D, Colella P, Sardiello M, Rubinsztein DC, Ballabio A. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332:1429–1433. https://doi.org/10.1126/science.1204592.
   PubMed Web of Science ®Google Scholar
• Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TA, Zou L, Xie XJ, Corey DR, Brugarolas J. 2011. Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:3242–3258. https://doi.org/10.1038/emboj.2011.257.
   PubMed Web of Science ®Google Scholar
• Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ, Gygi SP. 2008. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci U S A 105:10762–10767. https://doi.org/10.1073/pnas.0805139105.
   PubMed Web of Science ®Google Scholar
• Mayya V, Lundgren DH, Hwang SI, Rezaul K, Wu L, Eng JK, Rodionov V, Han DK. 2009. Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal 2:ra46. https://doi.org/10.1126/scisignal.2000007.
   PubMed Web of Science ®Google Scholar
• Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J, Kubica N, Hoffman GR, Cantley LC, Gygi SP, Blenis J. 2011. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332:1322–1326. https://doi.org/10.1126/science.1199484.
   PubMed Web of Science ®Google Scholar
• Ferron M, Settembre C, Shimazu J, Lacombe J, Kato S, Rawlings DJ, Ballabio A, Karsenty G. 2013. A RANKL-PKCbeta-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev 27:955–969. https://doi.org/10.1101/gad.213827.113.
   PubMed Web of Science ®Google Scholar
• Debbache J, Zaidi MR, Davis S, Guo T, Bismuth K, Wang X, Skuntz S, Maric D, Pickel J, Meltzer P, Merlino G, Arnheiter H. 2012. In vivo role of alternative splicing and serine phosphorylation of the microphthalmia-associated transcription factor. Genetics 191:133–144. https://doi.org/10.1534/genetics.111.135996.
   PubMedGoogle Scholar
• Sato S, Roberts K, Gambino G, Cook A, Kouzarides T, Goding CR. 1997. CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 14:3083–3092. https://doi.org/10.1038/sj.onc.1201298.
   PubMed Web of Science ®Google Scholar
• de la Serna IL, Ohkawa Y, Higashi C, Dutta C, Osias J, Kommajosyula N, Tachibana T, Imbalzano AN. 2006. The microphthalmia-associated transcription factor requires SWI/SNF enzymes to activate melanocyte-specific genes. J Biol Chem 281:20233–20241. https://doi.org/10.1074/jbc.M512052200.
   PubMed Web of Science ®Google Scholar
• Strub T, Giuliano S, Ye T, Bonet C, Keime C, Kobi D, Le Gras S, Cormont M, Ballotti R, Bertolotto C, Davidson I. 2011. Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30:2319–2332. https://doi.org/10.1038/onc.2010.612.
   PubMedGoogle Scholar
• Medina-Gomez G, Virtue S, Lelliott C, Boiani R, Campbell M, Christodoulides C, Perrin C, Jimenez-Linan M, Blount M, Dixon J, Zahn D, Thresher RR, Aparicio S, Carlton M, Colledge WH, Kettunen MI, Seppanen-Laakso T, Sethi JK, O'Rahilly S, Brindle K, Cinti S, Oresic M, Burcelin R, Vidal-Puig A. 2005. The link between nutritional status and insulin sensitivity is dependent on the adipocyte-specific peroxisome proliferator-activated receptor-gamma2 isoform. Diabetes 54:1706–1716. https://doi.org/10.2337/diabetes.54.6.1706.
   PubMed Web of Science ®Google Scholar
• Chiellini C, Costa M, Novelli SE, Amri EZ, Benzi L, Bertacca A, Cohen P, Del Prato S, Friedman JM, Maffei M. 2003. Identification of cathepsin K as a novel marker of adiposity in white adipose tissue. J Cell Physiol 195:309–321. https://doi.org/10.1002/jcp.10253.
   PubMed Web of Science ®Google Scholar
• Mikkelsen TS, Xu Z, Zhang X, Wang L, Gimble JM, Lander ES, Rosen ED. 2010. Comparative epigenomic analysis of murine and human adipogenesis. Cell 143:156–169. https://doi.org/10.1016/j.cell.2010.09.006.
   PubMed Web of Science ®Google Scholar
• Chomczynski P, Mackey K. 1995. Short technical reports. Modification of the TRI reagent procedure for isolation of RNA from polysaccharide- and proteoglycan-rich sources. Biotechniques 19:942–945.
   PubMed Web of Science ®Google Scholar
• Dacwag CS, Ohkawa Y, Pal S, Sif S, Imbalzano AN. 2007. The protein arginine methyltransferase Prmt5 is required for myogenesis because it facilitates ATP-dependent chromatin remodeling. Mol Cell Biol 27:384–394. https://doi.org/10.1128/MCB.01528-06.
   PubMed Web of Science ®Google Scholar